The makers of the cold and allergy medication Zicam have agreed to pay a $16 million settlement to resolve a class action lawsuit. According to the lawsuit, Zicam made “false and misleading statements about the effectiveness of certain Zicam products in violation of state and federal law.” Zicam is denying these claims. Continue reading “Zicam Settles False Advertising Class Action for $16 Million”